简体中文 | 繁體中文 | English

Products & Services News

2018-12-07 17:27 Toshiba Adds New 12TB and 14TB Helium-Sealed Models to Both the N300 NAS and X300 Performance Hard Drive Product Line
2018-12-07 16:41 FLIR Introduces Raymarine Element Series with Lifelike Sonar Imaging
2018-12-07 15:39 Citi Private Bank Issues Outlook 2019
2018-12-07 15:01 Pindrop Raises $90 Million Series D to Fuel Global Expansion
2018-12-07 14:56 Mitsui Mining & Smelting Co., Ltd. to Establish New Marketing Base for Copper Foil Business in China
2018-12-07 14:48 Welch’s Leverages Rimini Street Support for its Oracle E-Business Suite and Oracle Database
2018-12-07 13:15 IDEMIA’s biometrics and mobile-based CloudCard+ solution wins Best Payment Authentication Solution Award from JUNIPER research
2018-12-07 10:08 Internet Grows to 342.4 Million Domain Name Registrations in the Third Quarter of 2018
2018-12-07 10:05 Satoshi Is Coming Back Inc. Announces Exciting, Dramatic Crypto Whitepaper, U.S. Patent Assets and New Science Fiction
2018-12-07 10:02 Brii Biosciences Builds Innovative Pipeline, Forges Public-Private Partnerships to Bring Novel Medicines to Chinese Patients
2018-12-07 09:58 Harry Potter: Hogwarts Mystery Invites Players to Deck the Halls for Christmas in the Wizarding World
2018-12-06 17:41 Diligent’s Blueprint OneWorld and CSC Unveil a New Partnership Unifying Best-in-Class Global Entity Management and Registered Agent Services in One Package
2018-12-06 17:22 4G to Become the Dominant Mobile Technology in Latin America by the End of the Year, Finds New GSMA Report
2018-12-06 14:43 CMMI® Institute Expands CMMI® V2.0 to Include Services and Supplier Management
2018-12-06 14:00 Gemalto Pilots Biometric Boarding at Los Angeles International Airport
2018-12-06 12:41 New FinTech Survey Report Reveals the Importance of Adverse Media Screening
2018-12-06 12:36 FAA Approves AerSafe for Additional Airbus Aircraft to Comply with Fuel Tank Flammability Reduction Rule
2018-12-06 12:34 Carnot BioSciences, a Spin off of SmartZyme BioPharma, and Hemoshear Therapeutics Partner to Develop Protein-Based Therapeutics for Rare Metabolic Diseases
2018-12-06 10:18 EverZinc Invests in Zano®
2018-12-06 10:13 Seattle Genetics and Takeda Present Positive Data from Phase 3 ECHELON-2 Clinical Trial for ADCETRIS® (Brentuximab Vedotin) in Frontline Treatment of CD30-Expressing Peripheral T-Cell Lymphomas

Business Wire Weibo

Press Releases

Latest Releases